Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I have a feeling further positive results won't be well received by some:)
Sorry to hear of your loss dp70. I pray the God of salvation keeps you.
Negativism cannot touch Brilacidin so it's now badger a completely different past trial in trying to tarnish B's successes. P was a completely different compound in a completely different trial. B is our lead candidate.
Some set a artificial timetable and it hasn't come to fruition. Leo said things are going per industry standard however long that is.
There is money to be made in Covid treatments. Go B.
I can see some sort of aerosol program coming out of RBL testing results. I think good trial results will be a game changer for longs.
Yep joke of the day. Go B
Enemies of Leo I guess seems crazy. What's important is the B arm showing evidence of helping patients above standard of care. Good results should give Leo recognition and give strength to future plan updates. B has yet to have a failed outcome so there's that.
My .237 bid filled below the bid. For now they got to be purposely undermining share price. I figure a good pop on next update.
My thoughts exactly. Leo hasn't seen the need to throw out any fluff pr's which I read as a good sign. B has yet to fail a trial.
Hmm did you ask questions the last time you bought.
Yeah I was tipped off by other posters to take a closer look as It doesn't time line correct. I don't like to go to those other boards because of all the gifs and video nonsense.
B wins we all win. If doubted half as much I would have moved on. Life is too short.
Trial news will be delivered when ready. Meanwhile more testing going on behind the scenes.
Agree BP would want a good therapeutic even better a broad spectrum anti-viral. Last pr: "Brilacidin has shown potent and consistent inhibition in vitro against coronaviruses, alphaviruses and bunyaviruses (with laboratory testing against other viruses also underway), supporting Brilacidin’s potential to be developed as a broad-spectrum antiviral. The annual global antiviral drug market is estimated to reach $44 billion by 2026".
I think the ABSSSI trial is the epitome of comparisons. Eight weeks we are now only six.
Brilacidin for ABSSSI took 8 weeks. Why is that not mentioned. Data is not late.
Really looking forward to read out.
B is the phase 2 champ so crank up the heat.
Too bad you were not around to advise the Titanic. Go B
So if I'm reading this right the shot forced the virus to mutate and become even more virulent. If this is true maybe that's why there was no push for a SARS Cov-1 vaccine.
Yep and one can never build immunity to a cold.
This is not a car where you just take a look under the hood. The integrity of the trial must remain sound if not prepare for litigation. You've already said trial has failed how about making up your mind. Pick a side.
There is no cure we only have Treatments in which we hope B turns out to be a better treatment then what we have currently. Relax.
You still need to make it out of the hospital. That's where B comes in as Variants keep coming.
BP "stranglehold" is simply due to the huge dollars poured into the vaccines mandate, anti-virals were just not wholeheartedly funded. Anti-virals are now picking up support as variants get smarter. Go Bril
Don't forget B also heals Acute bacterial skin and skin structure infections (ABSSSI) in a single dose. I found the following a good write up.
https://absssi-education.com/
Yep that was a nice run a repeat would be fantastic.
We are maybe another two weeks away from data being released because slow and methodical is the way it works. Six weeks is nothing, B ABSSSI took eight. Right now we wait.
I think underestimating is what got us here.
There are some large pharmas running trials in Russia these days. If B shows improvement in combination with what ever anti-viral drug was used we have a winner.imo
Of course if there's another larger trial in Russia it may also be with what ever standard of care they provided if not Rem. Do we know what pharma provided that drug.
I believe they are just looking for a Rem + B efficacy signal. Both together offering more horsepower. We won't be going it alone. But that's just me.
My question is have you bought more since 2019?
Even with the Delta variant, the ability of COVID-19 vaccines to prevent hospitalization hasn't significantly dropped, CDC scientist says
https://www.yahoo.com/news/even-delta-variant-ability-covid-045427328.html
We need good antivirals now. Go B
Thanks, I copied Brilacidin starting at that current time discussing anti-bacterial, anti-inflammatory and discovered anti-viral properties.
Seems your link missed some characters. This one worked for me.
It took just eight weeks for the 208 patient ABSSSI trial. I give this by second week of September. These goal posts are getting heavy.